Zobrazeno 1 - 10
of 476
pro vyhledávání: '"CG Figdor"'
Autor:
E Lamers, J te Riet, M Domanski, R Luttge, CG Figdor, JGE Gardeniers, XF Walboomers, JA Jansen
Publikováno v:
European Cells & Materials, Vol 23, Pp 182-194 (2012)
Organised nanotopography mimicking the natural extracellular matrix can be used to control morphology, cell motility, and differentiation. However, it is still unknown how specific cell types react with specific patterns. Both initial adhesion and pr
Externí odkaz:
https://doaj.org/article/e5c3c249908942ed920c464f9244d5af
Autor:
Aa, Eggert, Mw, Schreurs, Oc, Boerman, Wim J.G. Oyen, Aj, Boer, Cj, Punt, Cg, Figdor, Gj, Adema
Publikováno v:
Europe PubMed Central
Dendritic cells (DCs) are professional antigen-presenting cells, well equipped to initiate an immune response. Currently, tumor antigen-derived peptide loaded DCs are used in clinical vaccination in cancer patients. However, the optimal dose and rout
Publikováno v:
Europe PubMed Central
Molecular analysis of small tissue samples has become increasingly important in biomedical studies. Using a laser dissection microscope and modified nucleic acid isolation protocols, we demonstrate that multiple mRNA as well as DNA sequences can be i
Autor:
Cj, Vennegoor, van de Wiel-van Kemenade E, Rj, Huijbens, Sanchez-Madrid F, Cj, Melief, Cg, Figdor
Publikováno v:
Europe PubMed Central
Patients with the leukocyte adhesion deficiency (LAD) syndrome have a genetic defect in the common beta 2-chain (CD18) of the leukocyte integrins. This defect can result in the absence of cell surface expression of all three members of the leukocyte
Publikováno v:
Blood. 76(7)
Monocytes activated by lipopolysaccharide (LPS) and interferon gamma (IFN gamma) rapidly secrete a number of monokines with different functional properties. Interleukin–4 (IL–4), a T-cell derived cytokine, has been shown to reduce the production
Publikováno v:
Blood. 60(1)
Human peripheral blood monocytes were isolated by counterflow centrifugation elutriation (CCE). This technique was modified in such a way that various monocyte fractions (viability greater than 99%) could be elutriated by increasing the density of th
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
Autor:
Eden T; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schaffrath AZ; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Wesolowski J; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Stähler T; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Tode N; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richter N; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schäfer W; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hambach J; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hermans-Borgmeyer I; Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Woens J; Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Le Gall CM; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Wendler S; ChromoTek GmbH, Martinsried, Germany - A part of Proteintech Group, Martinsried, Germany., Linke-Winnebeck C; ChromoTek GmbH, Martinsried, Germany - A part of Proteintech Group, Martinsried, Germany., Stobbe M; ChromoTek GmbH, Martinsried, Germany - A part of Proteintech Group, Martinsried, Germany., Budnicki I; Genovac GmbH, Freiburg, Germany., Wanney A; Genovac GmbH, Freiburg, Germany., Heitz Y; Genovac GmbH, Freiburg, Germany., Schimmelpfennig L; Genovac GmbH, Freiburg, Germany., Schweitzer L; Genovac GmbH, Freiburg, Germany., Zimmer D; Genovac GmbH, Freiburg, Germany., Stahl E; Preclinics GmbH, Potsdam, Germany., Seyfried F; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gebhardt AJ; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dieckow L; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Riecken K; Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fehse B; Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bannas P; Department of Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Magnus T; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Verdoes M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Figdor CG; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Hartlepp KF; ChromoTek GmbH, Martinsried, Germany - A part of Proteintech Group, Martinsried, Germany., Schleer H; Genovac GmbH, Freiburg, Germany., Füner J; Preclinics GmbH, Potsdam, Germany., Tomas NM; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Haag F; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rissiek B; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mann AM; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Menzel S; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Core Facility Nanobodies, University of Bonn, Bonn, Germany., Koch-Nolte F; Institute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nolte@uke.de.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 03; Vol. 15 (1), pp. 4728. Date of Electronic Publication: 2024 Jun 03.
Autor:
Weiss L; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Institute for Chemical Immunology, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., Classens R; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Schluck M; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., Grad E; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Dölen Y; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., van der Woude L; Department of Pathology, Radboudum, Geert Grooteplein 10, Nijmegen, GA 6525, The Netherlands., van Midden D; Department of Pathology, Radboudum, Geert Grooteplein 10, Nijmegen, GA 6525, The Netherlands., Maassen L; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Verrijp K; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., van Riessen K; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., van Dinther E; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Hagemann PM; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands., Figdor CG; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Institute for Chemical Immunology, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands., Hammink R; Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.
Publikováno v:
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 May 03; Vol. 7 (6), pp. 1874-1883. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
Autor:
Jäger E; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague, Czech Republic.; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands., Ilina O; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands., Dölen Y; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands., Valente M; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands., van Dinther EAW; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands., Jäger A; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague, Czech Republic., Figdor CG; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands., Verdoes M; Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands.
Publikováno v:
Biomacromolecules [Biomacromolecules] 2024 Mar 11; Vol. 25 (3), pp. 1749-1758. Date of Electronic Publication: 2024 Jan 18.
Autor:
Bol KF; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Schreibelt G; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Bloemendal M; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., van Willigen WW; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Hins-de Bree S; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., de Goede AL; Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands., de Boer AJ; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Bos KJH; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Duiveman-de Boer T; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Olde Nordkamp MAM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., van Oorschot TGM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Popelier CJ; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Pots JM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Scharenborg NM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., van de Rakt MWMM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., de Ruiter V; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., van Meeteren WS; Department of Dermatology, Radboud university medical center, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud university medical center, Nijmegen, The Netherlands., Croockewit SJ; Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands., Koeneman BJ; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Creemers JHA; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Wortel IMN; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands., Angerer C; Miltenyi Biotec, Bergisch Gladbach, Germany., Brüning M; Miltenyi Biotec, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec, Bergisch Gladbach, Germany., Dzionek A; Miltenyi Biotec, Bergisch Gladbach, Germany., van der Veldt AA; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., van Grünhagen DJ; Department Surgical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands., Werner JEM; Department Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Bonenkamp JJ; Department Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Haanen JBAG; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Boomsma MF; Department of Radiology, Isala Oncology Center, Zwolle, The Netherlands., Aarntzen EHJ; Department of Medical Imaging, Radboud university medical center, Nijmegen, The Netherlands., Gotthardt M; Department of Medical Imaging, Radboud university medical center, Nijmegen, The Netherlands., Nagarajah J; Department of Medical Imaging, Radboud university medical center, Nijmegen, The Netherlands., de Witte TJM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., Figdor CG; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands., de Wilt JHW; Department Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Textor J; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.; Department of Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands., de Groot JWB; Department of Medical Oncology, Isala Oncology Center, Zwolle, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., de Vries IJM; Medical Biosciences, Radboud Institute for Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands. Jolanda.deVries@radboudumc.nl.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 23; Vol. 15 (1), pp. 1632. Date of Electronic Publication: 2024 Feb 23.